VFVictoria Domingues Ferraz

Victoria Domingues Ferraz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victoria Domingues Ferraz has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex‐Specific Differences in Visceral and Subcutaneous Adiposity Accumulation and Their Association With Metabolic Abnormalities

    by Isa Galvão Rodrigues, Gabriela Maria Pereira Floro Arcoverde, Camila Lima Chagas Do Nascimento, Victoria Domingues Ferraz, Nadja Fernandes da Silva, Ilma Kruze Grande de Arruda, Cláudia Porto Sabino Pinho, Dário Celestino Sobral Filho

    Some studies suggest that body fat distribution differs between sexes; there remains a gap regarding the exact mechanisms that regulate these differences and their cardiometabolic consequences. This study investigated sex‐specific differences influencing the concentration and metabolic risk associated with visceral abdominal adipose tissue (VAT) and subcutaneous adipose tissue (SAT). This cross‐sectional study includes outpatients from a university‐affiliated public hospital. Consecutive patients aged ≥ 20 years were included in our sample. VAT and SAT were measured using ultrasound (the mean of three attempts). Intra‐ and interevaluator reproducibility was tested, demonstrating high reliability (> 0.90) for both VAT and SAT. Demographic (age, sex, and self‐reported race), anthropometric, behavioral, and biochemical variables were assessed. A total of 253 patients were included. They had a mean age of 46.3 ± 11.6 years (64.4% females and 68.7% non‐white). Although the mean total abdominal adipose tissue was similar between sexes ( p = 0.125), males exhibited a higher mean VAT (7.3 ± 3.0 vs. 6.0 ± 2.1 cm; p < 0.001), while women presented with a higher mean SAT (3.4 ± 1.2 vs. 2.7 ± 1.4 cm; p < 0.001). Among females, VAT was directly associated with serum triglycerides (TG), TG/HDL ratio, blood glucose, and glycated hemoglobin (HbA1c), and inversely associated with HDL. VAT/SAT ratio predicted higher levels of total cholesterol (TC), LDL, TG, TG/HDL ratio, glucose, and HbA1c ( p < 0.05). Among males, VAT did not significantly affect metabolic alterations. In conclusion, within the same mean BMI, males had higher VAT concentrations, whereas in females, despite lower VAT, a worse adverse metabolic profile was observed.


  • Is phase angle associated with visceral adiposity and cardiometabolic risk in cardiology outpatients?

    by Victoria Domingues Ferraz, Jarson Pedro da Costa Pereira, Claudia Porto Sabino Pinho Ramiro, Gabriela Maria Pereira Floro Arcoverde, Isa Galvão Rodrigues, Camila Lima Chagas, José Reginaldo Alves de Queiroz, Maria Conceição Chaves de Lemos, Alcides da Silva Diniz, Ilma Kruze Grande de Arruda

    Background/objectives Phase angle (PhA) serves as a prognostic marker in various clinical scenarios, reflecting oxidative stress and cellular damage. Despite its clinical relevance, its connection with adiposity and cardiovascular risk markers remains underexplored. Hence, our study sought to investigate the relationship between PhA and metabolic, adiposity, and cardiovascular risk parameters among outpatients with cardiology diagnosis. Subjects/methods Adults aged between 26 and 59 years, under the care of a cardiology unit, were included. Ultrasound imaging was used to assess visceral adipose tissue (VAT). Single-frequency bioelectrical impedance analysis (BIA) [50 kHz] was employed to calculate PhA, from BIA’s resistance and reactance measurements. Muscle strength, body mass index, waist circumference, and waist-to-height ratio were also evaluated. Framingham’s risk score was calculated to estimate the cardiovascular risk events. Metabolic blood samples’ results were obtained from medical records. Results One hundred and five participants were included in our study. Low PhA was observed in 29.5% of our sample. Higher PhA values were independently and inversely associated with both higher VAT and cardiovascular risk (adjusted OR: 0.79 [95% CI 0.69;0.91], OR: 0.74 [95% CI 0.60;0.89], respectively). Lower PhA values (≤5.59) were goodly associated with high VAT (AUC: 0.82 p < 0.001). Lower PhA values (≤5.06) were fairly associated with higher cardiovascular risk (AUC: 0.70 p = 0.003). Conclusion Our study provides evidence that PhA is independently and inversely associated with elevated VAT and cardiovascular risk. These findings underscore the potential of PhA as a valuable complementary marker in assessing cardiometabolic health.